Moderate vs Deep Neuromuscular Block on Biotrauma During Laparoscopy
NCT ID: NCT03576118
Last Updated: 2020-06-11
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
74 participants
INTERVENTIONAL
2018-11-05
2019-09-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Deep vs Moderate Block: Impact on Operating Conditions & Patient Satisfaction
NCT02794714
Moderate vs Deep Neuromuscular Block in Lower Pressure Pneumoperitoneum
NCT05689957
Deep Neuromuscular Block Affect the Quality of Recovery After Laparoscopic Hysterectomy
NCT06469866
Analgesic Effects of US Bilateral Rectus Sheath Block for Laparoscopic GY Surgery
NCT02476799
Pre Operative Transversus Abdominis Plane Block Laparoscopic Gynecological Surgery
NCT01075074
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The benefits of deep neuromuscular blocks for laparoscopic procedures are controversial and most of the studies undertaken have only sought to improve surgical conditions. Theoretically, deep neuromuscular block permits a lower abdominal insufflation pressure, which leads to better respiratory mechanics and gas exchange. The investigators examined the effects of moderate vs. deep neuromuscular block on respiratory mechanics and biotrauma in patients with intraoperative protective lung ventilation for laparoscopy. The investigators hypothesized that deep neuromuscular block (PTC 1 or 2) and low pressure pneumoperitoneum (8 mmHg) would improve respiratory mechanics and reduce inflammatory processes associated with biotrama during mechanical ventilation compared with moderate neuromuscular block (TOF count 1 or 2 ) and standard pressure pneumoperitoneum (12-15 mmHg).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Deep neuromuscular block
Deep neuromuscular relaxation and low pressure pneumoperitoneum
Deep neuromuscular block
Deep neuromuscular block using high dose rocuronium and 8 mmHg pneumoperitoneum
Moderate neuromuscular block
Moderate neuromuscular relaxation and standard pressure pneumoperitoneum
Moderate neuromuscular block
Moderate neuromuscular block using moderate dose rocuronium and 12-15 mmHg pneumoperitoneum
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Deep neuromuscular block
Deep neuromuscular block using high dose rocuronium and 8 mmHg pneumoperitoneum
Moderate neuromuscular block
Moderate neuromuscular block using moderate dose rocuronium and 12-15 mmHg pneumoperitoneum
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* uncontrolled hypertension, asthma, COPD
* neuromuscular disorder
* patients who have had abdominal surgery
* morbid obesity (body mass index \> 35 kg/m2)
25 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ajou University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jong Yeop Kim
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jong Yeop Kim
Role: PRINCIPAL_INVESTIGATOR
Ajou University Hospital, Suwon, Gyeongki-do, Korea,
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ajou University Hospital
Suwon, Gyeonggi-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AJIRB-MED-OBS-18-115
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.